(Q34235741)

English

KSAC, a defined Leishmania antigen, plus adjuvant protects against the virulence of L. major transmitted by its natural vector Phlebotomus duboscqi

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

31 July 2017

KSAC, a defined Leishmania antigen, plus adjuvant protects against the virulence of L. major transmitted by its natural vector Phlebotomus duboscqi (English)

1 reference

Europe PubMed Central

31 July 2017

Phlebotomus duboscqi

object named as

Phlebotomus duboscqi

1 reference

based on heuristic

inferred from title

object named as

Yasuyuki Goto

7

0 references

Fabiano Oliveira

object named as

Fabiano Oliveira

3

0 references

10

object named as

Steven G Reed

1 reference

Europe PubMed Central

31 July 2017

Jesus G Valenzuela

11

object named as

Jesus G Valenzuela

1 reference

Europe PubMed Central

31 July 2017

author name string

Regis Gomes

1

1 reference

Europe PubMed Central

31 July 2017

Clarissa Teixeira

2

1 reference

Europe PubMed Central

31 July 2017

Phillip G Lawyer

4

1 reference

Europe PubMed Central

31 July 2017

Dia-Eldin Elnaiem

5

1 reference

Europe PubMed Central

31 July 2017

Claudio Meneses

6

1 reference

Europe PubMed Central

31 July 2017

Ajay Bhatia

8

1 reference

Europe PubMed Central

31 July 2017

Randall F Howard

9

1 reference

Europe PubMed Central

31 July 2017

Shaden Kamhawi

12

1 reference

Europe PubMed Central

31 July 2017

language of work or name

0 references

publication date

3 April 2012

1 reference

Europe PubMed Central

31 July 2017

PLoS Neglected Tropical Diseases

1 reference

Europe PubMed Central

31 July 2017

6

1 reference

Europe PubMed Central

31 July 2017

4

1 reference

Europe PubMed Central

31 July 2017

e1610

1 reference

Europe PubMed Central

31 July 2017

copyright license

Creative Commons CC0 License

3 April 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted, dedicated to the public domain by copyright holder

0 references

KSAC, the first defined polyprotein vaccine candidate for visceral leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317914

6 July 2018

Vaccines for the leishmaniases: proposals for a research agenda

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317914

6 July 2018

Development and characterization of synthetic glucopyranosyl lipid adjuvant system as a vaccine adjuvant

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317914

6 July 2018

A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with sodium stibogluconate for the treatment of mucosal leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317914

6 July 2018

Leishmaniasis Vaccine: Where are We Today?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317914

6 July 2018

Treatment of canine visceral leishmaniasis by the vaccine Leish-111f+MPL-SE.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317914

6 July 2018

Optimized subunit vaccine protects against experimental leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317914

6 July 2018

Physicochemical characterization and biological activity of synthetic TLR4 agonist formulations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317914

6 July 2018

Vector transmission of leishmania abrogates vaccine-induced protective immunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317914

6 July 2018

In vivo imaging reveals an essential role for neutrophils in leishmaniasis transmitted by sand flies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317914

6 July 2018

Immunity to distinct sand fly salivary proteins primes the anti-Leishmania immune response towards protection or exacerbation of disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317914

6 July 2018

Leish-111f, a recombinant polyprotein vaccine that protects against visceral Leishmaniasis by elicitation of CD4+ T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317914

6 July 2018

Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317914

6 July 2018

Synthetic glycovaccine protects against the bite of leishmania-infected sand flies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317914

6 July 2018

The development of effector and memory T cells in cutaneous leishmaniasis: the implications for vaccine development.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317914

6 July 2018

The immunology of susceptibility and resistance to Leishmania major in mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317914

6 July 2018

Immunization with a polyprotein vaccine consisting of the T-Cell antigens thiol-specific antioxidant, Leishmania major stress-inducible protein 1, and Leishmania elongation initiation factor protects against leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317914

6 July 2018

Real-time PCR for detection and quantitation of leishmania in mouse tissues

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317914

6 July 2018

The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317914

6 July 2018

Leishmaniasis: current status of vaccine development

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317914

6 July 2018

Human and murine immune responses to a novel Leishmania major recombinant protein encoded by members of a multicopy gene family.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317914

6 July 2018

The regulation of immunity to Leishmania major

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317914

6 July 2018

The present and future of vaccination for cutaneous leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317914

6 July 2018

T-cell responses and immunity to experimental infection with leishmania major

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317914

6 July 2018

Functional heterogeneity of CD4+ T cells in leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317914

6 July 2018

Focus: Leishmaniasis

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0001610

21 January 2018

Immune elimination of Leishmania major in mice: implications for immune memory, vaccination, and reactivation disease

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0001610

21 January 2018

A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with meglumine antimoniate for the treatment of cutaneous leishmaniasis

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0001610

21 January 2018

Evaluation of an immunochemotherapeutic protocol constituted of N-methyl meglumine antimoniate (Glucantime) and the recombinant Leish-110f + MPL-SE vaccine to treat canine visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0001610

21 January 2018

Protective efficacy of a tandemly linked, multi-subunit recombinant leishmanial vaccine (Leish-111f) formulated in MPL adjuvant

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0001610

21 January 2018

A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine for use in the prevention of visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0001610

21 January 2018

Protection Against Cutaneous Leishmaniasis Resulting from Bites of Uninfected Sand Flies

1 reference

https://pubmed.ncbi.nlm.nih.gov/22509423

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effectiveness of leishmanization in the control of cutaneous leishmaniasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22509423

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/22509423

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PNTD.0001610

1 reference

Europe PubMed Central

31 July 2017

1 reference

Europe PubMed Central

31 July 2017

1 reference

Europe PubMed Central

31 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34235741&oldid=2150157891"